Time to ART initiation among patients treated for rifampicin-resistant tuberculosis in Khayelitsha, South Africa: impact on mortality and treatment success

We conducted a retrospective cohort study of HIV-infected RR-TB patients not on ART at initiation of second-line anti-tuberculosis treatment. Our outcome measurements were time to ART initiation and RR-TB treatment outcomes